ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma

ClinicalTrials.gov ID: NCT00310037

Public ClinicalTrials.gov record NCT00310037. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 1:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase II Trial of Maintenance vs Consolidation Bortezomib Therapy Following Aggressive Chemo-Immunotherapy and Autologous Stem Cell Transplant for Previously Untreated Mantle Cell Lymphoma

Study identification

NCT ID
NCT00310037
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
151 participants

Conditions and interventions

Interventions

  • bortezomib Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 69 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Nov 30, 2013
Completion
May 31, 2022
Last update posted
Oct 27, 2025

2006 – 2022

United States locations

U.S. sites
48
U.S. states
8
U.S. cities
29
Facility City State ZIP Site status
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115
Illinois CancerCare - Bloomington Bloomington Illinois 61701
St. Joseph Medical Center Bloomington Illinois 61701
Graham Hospital Canton Illinois 61520
Illinois CancerCare - Canton Canton Illinois 61520
Illinois CancerCare - Carthage Carthage Illinois 62321
Memorial Hospital Carthage Illinois 62321
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Eureka Community Hospital Eureka Illinois 61530
Illinois CancerCare - Eureka Eureka Illinois 61530
Galesburg Clinic, PC Galesburg Illinois 61401
Illinois CancerCare - Galesburg Galesburg Illinois 61401
Illinois CancerCare - Havana Havana Illinois 62644
Mason District Hospital Havana Illinois 62644
Illinois CancerCare - Kewanee Clinic Kewanee Illinois 61443
Illinois CancerCare - Macomb Macomb Illinois 61455
McDonough District Hospital Macomb Illinois 61455
Illinois CancerCare - Monmouth Monmouth Illinois 61462
OSF Holy Family Medical Center Monmouth Illinois 61462
BroMenn Regional Medical Center Normal Illinois 61761
Community Cancer Center Normal Illinois 61761
Illinois CancerCare - Community Cancer Center Normal Illinois 61761
Community Hospital of Ottawa Ottawa Illinois 61350
Oncology Hematology Associates of Central Illinois, PC - Ottawa Ottawa Illinois 61350
Illinois CancerCare - Pekin Pekin Illinois 61603
Proctor Hospital Peoria Illinois 61614
CCOP - Illinois Oncology Research Association Peoria Illinois 61615
Oncology Hematology Associates of Central Illinois, PC - Peoria Peoria Illinois 61615
Methodist Medical Center of Illinois Peoria Illinois 61636
OSF St. Francis Medical Center Peoria Illinois 61637
Illinois CancerCare - Peru Peru Illinois 61354
Illinois Valley Community Hospital Peru Illinois 61354
Illinois CancerCare - Princeton Princeton Illinois 61356
Perry Memorial Hospital Princeton Illinois 61356
Illinois CancerCare - Spring Valley Spring Valley Illinois 61362
Dana-Farber/Brigham and Women's Cancer Center Boston Massachusetts 02115
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston Massachusetts 02115
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis Missouri 63110
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756-0002
Roswell Park Cancer Institute Buffalo New York 14263-0001
Monter Cancer Center of the North Shore-LIJ Health System Lake Success New York 11042
CCOP - North Shore University Hospital Manhasset New York 11030
Don Monti Comprehensive Cancer Center at North Shore University Hospital Manhasset New York 11030
Long Island Jewish Medical Center New Hyde Park New York 11040
SUNY Upstate Medical University Hospital Syracuse New York 13210
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus Ohio 43210-1240

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00310037, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2025 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00310037 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →